The pharmaceutical firm said a weekly 2.4-milligram dose of semaglutidethe generic name for both Wegovy and Ozempicresulted in a 20% reduction in heart attacks and strokes, following a five-year trial that involved over 17,600 participants aged 45 or older
If that context applies to you, use the safety and status information on the BPC-157 pages and prioritise official anti-doping guidance
While the findings are encouraging, it is crucial for women considering GLP-1 agonists to consult with a healthcare provider to determine if these medications are suitable for their individual needs
2023 Jul 29;24(15):12152
Both medications work by mimicking the effects of GLP-1, stimulating insulin secretion, reducing glucagon secretion, and slowing gastric emptying, which helps regulate blood sugar levels and promote weight loss
doi: 10.1016/j.bmc.2011.10.007